Andrew Kenler, MD
About
Appointments
Surgical Oncology
Assistant Clinical ProfessorPrimary
Other Departments & Organizations
Education & Training
- MD
- Cornell University Medical College (1988)
- BS
- Tufts University (1984)
Research
Publications
2024
ASO Visual Abstract: Cryoablation without Excision for Early Stage Breast Cancer; ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence
Fine R, Gilmore R, Tomkovich K, Dietz J, Berry M, Hernandez L, Columbus K, Seedman S, Fisher C, Han L, Manahan E, Hicks R, Vaidya R, Curcio L, Sevrukov A, Kenler A, Taback B, Chen M, Miller M, Gold L, Anglin B, Aoun H, Simmons R, Feldman S, Boolbol S. ASO Visual Abstract: Cryoablation without Excision for Early Stage Breast Cancer; ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence. Annals Of Surgical Oncology 2024, 1-2. DOI: 10.1245/s10434-024-16272-y.Peer-Reviewed Original ResearchCryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence
Fine R, Gilmore R, Tomkovich K, Dietz J, Berry M, Hernandez L, Columbus K, Seedman S, Fisher C, Han L, Manahan E, Hicks R, Vaidya R, Curcio L, Sevrukov A, Kenler A, Taback B, Chen M, Miller M, Gold L, Anglin B, Aoun H, Simmons R, Feldman S, Boolbol S. Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence. Annals Of Surgical Oncology 2024, 31: 7273-7283. PMID: 39283572, PMCID: PMC11452421, DOI: 10.1245/s10434-024-16181-0.Peer-Reviewed Original ResearchCitationsAltmetricConceptsIpsilateral breast tumor recurrenceEarly-stage breast cancerBreast tumor recurrenceTumor recurrenceAdverse eventsBreast cancerEpidermal growth factor receptor 2 (HER2)-negativeHuman epidermal growth factor receptor 2 (HER2)-negativeIpsilateral breast tumor recurrence ratesHormone receptor (HR)-positivePatients meeting eligibilityDevice-related adverse eventsNon-operative treatment optionsHistological grade 1Institutional review board approvalPotential surgical risksEfficacy of cryoablationInvasive ductal carcinomaAlternative to surgeryLow-risk patientsPrimary study endpointFollow-up periodMinimally invasive procedureQuality-of-life scoresReview board approval